HDAC9 and neuroblastoma: Indeed, former studies demonstrated the cytotoxicity of HDAC inhibitors to several neuroblastoma cells, resulting in growth inhibition of these tumor cells (Cinatl et al., 1996; Michaelis et al,2004, 2007; Furchert et al., 2007).